Cevat İlteriş Kıkılı

6PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCell physiologyGene and molecular therapyNanotoxicology, health and safetyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 21, 2026
Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer.

|Sep 08, 2026
Clinicopathologic Features of NRG1 Fusion-Positive Non-Small Cell Lung Cancer.

|Apr 22, 2026
The Clinical Significance of Gallium-68 PSMA-11 PET-Derived SUVmax in the Management of Metastatic Hormone-Sensitive Prostate Cancer.

|Jul 03, 2025
Real World Efficacy and Safety of Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Liver Transplant Recipients.

Erdem Bektas, Aysenur Yilmaz, Cevat Ilteris Kikili

|Apr 23, 2025
Virological and Biochemical Effects of Tenofovir Alafenamide in Different Patient Groups With Chronic Hepatitis B Virus Infection in Real-World Cohort.

Erdem Bektas, Aysenur Yilmaz, Cevat Ilteris Kikili

|Apr 02, 2025
Late-onset recurrent immune checkpoint inhibitor-related pneumonitis after cessation of pembrolizumab: a case report.

Bahadır Köylü, Cevat İlteriş Kıkılı, Öner Dikensoy

Pageof 1

Frequent Collaborators

4 joint publications

Bahadır Köylü

3 joint publications

Fatih Selçukbiricik

2 joint publications

Erdem Bektas

2 joint publications

Aysenur Yilmaz